Target intelligence / Profile preview

T cell antigen CD3 (CD3)

Target
CD3
Molecular classification
Receptor (as part of the T cell receptor complex), Immune receptor complex, Immunoglobulin superfamily (for extracellular domains), Signal transduction molecule
01

Overview

CD3 is a **multimeric protein complex and T cell co-receptor**, composed of four invariant transmembrane chains: CD3ε (epsilon), CD3γ (gamma), CD3δ (delta), and CD3ζ (zeta)[4][3]. These assemble as heterodimers (CD3γε, CD3δε) plus a ζζ homodimer, and associate noncovalently with the antigen-specific T cell receptor (TCR), either αβ or γδ[5][6][8]. CD3 is essential for **T cell activation**: it transduces signals from the TCR after antigen recognition by its intracellular Immunoreceptor Tyrosine-based Activation Motifs (ITAMs)[4][2][3]. The complex is a **key marker of T cell lineage**, extensively used in diagnosis and as a therapeutic target. Engagement of CD3 with agonist or antagonist antibodies profoundly modulates T cell function—leading to its clinical use in immunosuppression (e.g., transplant rejection, type 1 diabetes) and as a point of therapeutic redirection in cancer immunotherapy[5][7]. CD3 is also a **crucial component in structurally stabilizing the TCR complex** and organizing activation signals, with its structure and signaling mechanisms being the focus of extensive immunological research[4][5][6].

Other names
Cluster of differentiation 3T3 complexCD3 complexCD3ε (CD3 epsilon chain)CD3γ (CD3 gamma chain)CD3δ (CD3 delta chain)CD3ζ (CD3 zeta chain)
02

Mechanism of action

Antibody-mediated receptor modulation (e.g., anti-CD3 antibodies bind CD3, alter T cell activation, induce cell depletion or immunomodulation) Signal transduction inhibition or activation (by modulating TCR signaling through CD3 engagement) Immunosuppressive cytotoxicity (depletion of T cells via complement- and cell-mediated cytotoxicity, especially with murine antibodies) T cell redirection (bispecific T cell engagers, CAR-T)

03

Biological functions

T cell activationSignal transductionAntigen recognition (via TCR association)Immune response (both adaptive and innate via γδ T cells)T cell development
04

Disease associations

Cancer (important in immunotherapeutic targeting, e.g., CAR-T and bispecific antibodies)Autoimmune disease (targeted in immunosuppression, e.g., transplant)Infection (critical in antiviral and antimicrobial immune response)Other immune-mediated diseases
05

Safety considerations

Cytokine release syndrome (CRS) (prominent with anti-CD3 mAbs)Immunosuppression (risk of infections due to T cell depletion)Anaphylaxis/hypersensitivity (particularly with murine antibodies)Autoimmunity flare (paradoxical activation)Transient leukopeniaInfusion reactions
06

Interacting drugs

Muromonab-CD3 (OKT3, an anti-CD3 monoclonal antibody)

3 more in the full profile.

07

Biomarkers

CD3 expression on T cells (used to identify T-cells in diagnosis and monitoring)CD3+ cell count (for patient immune status)CD3 immunohistochemistry (for lymphoma and immune disorders)

Beyond the preview

Go deeper on T cell antigen CD3 (CD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell antigen CD3 (CD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call